Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
Clinical trial NCT03806790 · COMPLETED
Trial details
- NCT number
- NCT03806790
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2019-06-10
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.